Search In this Thesis
   Search In this Thesis  
العنوان
IMPACT OF METABOLIC SYNDROME ON IMPACT OF METABOLIC SYNDROME ON SEVERITY AND PROGNOSIS OF chrONIC OBSTRUCTIVE PULMONARY DISEASE \
المؤلف
Samah Mohamed El-Sagher Abd El-Lateef
هيئة الاعداد
باحث / سماح محمد الصغير عبد اللطيف
مشرف / مصطفى حسن رجب
مشرف / هوايده محمد كمال
مشرف / محمود سري البخاري
تاريخ النشر
2023.
عدد الصفحات
149 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الطب الرئوي والالتهاب الرئوى
تاريخ الإجازة
1/1/2023
مكان الإجازة
جامعة عين شمس - معهد البيئة - العلوم الطبية البيئية
الفهرس
Only 14 pages are availabe for public view

from 149

from 149

Abstract

Background: chronic obstructive pulmonary disease (COPD) a common preventable and treatable disease, is characterized by persistent airflow limitation that is usually progressive and associated with enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Aim of the study: This study aimed to determine the impact of Metabolic Syndrome in patients with chronic obstructive pulmonary disease. Patients and methods: This study was carried out on 60 subjects of both sexes, who were presented to Chest Outpatient Clinic. Patients were presented with signs and symptoms of COPD and proven radiologically, according to the GOLD guidelines. Subjects were categorized into two groups; 30 COPD patients with Metabolic Syndrome (group A) and 30 COPD patients without Metabolic Syndrome (group B). Results: There are 22 men and 8 women in the group of COPD with Metabolic Syndrome with mean age of 56.73 years, while in the group of COPD without Metabolic Syndrome, there were 19 men and 11 women with mean age of 61.1 years. The percentage of current smokers was high in all groups. There were statistically significant differences between the studied groups regarding BMI and waist circumference. There were statistically significant differences between the studied groups regarding systolic and diastolic blood pressure, fasting blood glucose, HbA1c, total cholesterol, LDL cholesterol and serum triglycerides. Regarding spirometry measures, there are statistically significant differences between the studied groups. Regarding GOLD, there was statistically non-significant difference between the studied groups. The frequency of Metabolic Syndrome was the highest in COPD patients in GOLD stage II. Conclusion: The presence of Metabolic Syndrome is substantial among COPD patients, especially in early stages (GOLD stages I−II). When the components of Metabolic Syndrome were evaluated separately, abdominal obesity, hypertension, and hyperglycemia were significantly more in both patients’group.